WASHINGTON - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to free speech.
LONDON - After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics - but not just yet.
CHICAGO - Poultry veterinarians in Minnesota believe an outbreak of avian flu has spread between farms, indicating the implementation of a U.S. strategy to contain the deadly bird disease failed in at least some cases.
- Europe's medicines regulator said on Wednesday it would restrict experts and committee members who intend to work for a pharmaceutical company from participating in the evaluation of medicines, in a move to reduce conflict of interests.
CARACAS - Venezuela is investigating whether drug companies including Germany's Merck KGaA and Bayer AG have improperly profited from subsidized foreign exchange amid growing medicine shortages, the country's health minister said.
- Alexion Pharmaceuticals Inc on Wednesday said it agreed to buy Synageva BioPharma Corp for $8.4 billion, more than twice its market value, to expand its offering of potentially high-priced medicines for rare diseases. | Video
LONDON - Europe will face an obesity crisis of vast proportions by 2030, according to new World Health Organization projections, with many countries likely to see far more than half of adults above the healthy weight limit.
BEIJING - China has begun a new campaign against illegal prenatal gender tests and sex-selective abortions to help address the country's gender imbalance, state news agency Xinhua said on Wednesday.
LONDON - European regulators do not agree with the negative view expressed by one adviser about the efficacy of UniQure's drug Glybera, the Western world's first gene therapy.